CVA Related New Coverage
-
Ascendiant Capital Starts Covanta (CVA) at Buy
-
JPMorgan Starts Covanta (CVA) at Overweight
-
Capstone Investments Starts Covanta (CVA) at Buy
-
Lazard Capital Starts Covanta (CVA) at Buy
-
Morgan Stanley Starts Covanta (CVA) at Equalweight
-
KeyBanc Starts Covanta (CVA) at Buy; Free Cash Flow Machine; Recent Headwinds Moderating, Possibly Reversing
-
Wedbush Starts Covanta (CVA) at Outperform; Growth Catalysts and Under-Leveraged Balance Sheet
-
Baird Starts Covanta (CVA) at Outperform
-
Wunderlich Securities Initiates Coverage on Covanta Holdings (CVA) with a Buy; Low Risk Play
-
Bank of America Resumes Coverage on Covanta (CVA) with an Underperform
-
Jefferies & Co Initiates Coverage on Covanta (CVA) with a Buy
-
American Technology Research Reinstates Coverage on Covanta (CVA) with a Buy
-
Stanford Group Initiates Coverage on Covanta (CVA) with a Buy
-
Broadpoint Capital Initiates Coverage on Covanta (CVA) with a Buy
-
Banc of America Starts Covanta (CVA) at Buy
-
Lehman Brothers Starts Covanta (CVA) at Overweight
-
Merrill Lynch initiates coverage on Covanta Holdings (CVA) with a Neutral
-
JP Morgan Starts Covanta Holdings (CVA) at Neutral
-
Avondale Partners Initiates Coverage on CVA with Market Outperform
-
Oppenheimer Starts CVA at Buy
Back to CVA Stock Lookup
